Board of Directors
Brian Weitzner Director Linkedin | Web Outpace Bio
Dr. Brian Weitzner is the Director of Computational and Structural Biology at Outpace Bio, where he uses protein design to develop the next generation of cell-based immunotherapies for cancers. His research is focused on using and deepening our understanding of protein sequence–structure–function relationships to design novel proteins to address problems in human health. In addition to his scientific expertise, Brian brings experience with research software development and community building practices as an active contributor to Rosetta Commons and founding member of OpenFold.
Clara Christ Director Twitter | Linkedin Bayer AG
Dr. Clara Christ is the Vice President, Head of Molecular Design at Bayer AG where her team focuses on advancing drug discovery projects with structural insights and digital means. She has worked as a computational chemist at Bayer AG since 2013 focusing on drug design in the therapy area oncology. Besides giving computational chemistry support in all stages of research projects she has been working on improving methods in the areas of de novo design, structure property analysis, and binding affinity prediction. Clara represents Bayer AG in the Open Free Energy Consortium.
David L. Mobley President, Co-Founder Twitter | Linkedin | Web University of California, Irvine
Prof. David Mobley holds a joint appointment in the Pharmaceutical Sciences and Department of Chemistry at the University of California, Irvine. A major focus of his research is the binding of small-molecule ligands to proteins, including development, application and validation of binding free energy methods. David is a strong proponent of open science and engaged in a series of community-driven projects and activities, such as spearheading the the SAMPL challenges and co-leading the Open Force Field Initiative. He also serves on the editorial boards of several journals and is a founding and managing editor for the Living Journal of Computational Molecular Science. David co-founded OMSF and currently serves as the President of the OMSF Board of Directors.
Karmen Čondić-Jurkić Executive Director, Co-Founder Twitter | LinkedIn Open Molecular Software Foundation
Dr. Karmen Čondić-Jurkić is the co-founder and Executive Director of the Open Molecular Software Foundation. She also currently serves as the Board’s Treasurer and Secretary. She has a background in computational chemistry. During her postdoc years, she developed a passion for open science and research infrastructure. She is particularly interested in collaboration and coordination of efforts, and how to make the research infrastructure more robust, sustainable and accessible. Karmen was the project manager for the Open Force Field Initiative before stepping into the role of OMSF Executive Director.
Michael K. Gilson Director Twitter | LinkedIn | Web University of California, San Diego
Mike Gilson, MD, PhD, is Professor and Chair in Computer-Aided Drug Design at the Skaggs School of Pharmacy and Pharmaceutical Sciences and co-director of the Center for Drug Discovery Innovation at the University of California San Diego. He is also a member of the Executive Committee of the UC Drug Discovery Consortium. A central theme of his research groups is advancing the technologies of computer-aided drug design (CADD), including protein-ligand binding thermodynamics, and force field development and validation. Mike has a long history of contributing to molecular sciences and following open science principles, including founding BindingDB, co-directing Drug Design Data Resource (D3R), and by holding community-wide, blinded prediction challenges. Mike is also one of the PIs leading the Open Force Field Initiative and serves on editorial boards of several journals.